Cardiovascular Outcomes with Sotagliflozin

To the Editor: In the SOLOIST-WHF trial (Effect of Sotagliflozin on Cardiovascular Events in Patients with Type 2 Diabetes Post Worsening Heart Failure), Bhatt et al. (Jan. 14 issue) 1 report that death from cardiovascular causes and hospitalizations and urgent visits for heart failure (the composit...

Full description

Bibliographic Details

Published in:	The New England journal of medicine Vol. 384; no. 15; pp. 1470 - 1473
Main Authors:	Baglioni, Piero, Marchand, Lucien, Villar, Emmanuel, Green, Lisa, Bhatt, Deepak L, Steg, P. Gabriel, Pitt, Bertram
Format:	Journal Article
Language:	English
Published:	United States Massachusetts Medical Society 15.04.2021
Subjects:	Cardiovascular diseases Congestive heart failure Diabetes Diabetes mellitus (non-insulin dependent) Diabetic Ketoacidosis Glycosides Heart failure Humans Mortality Placebos Renal Insufficiency, Chronic
ISSN:	0028-4793, 1533-4406, 1533-4406
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!